GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 124 filers reported holding GENOMIC HEALTH INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,459,000 | -88.8% | 25,084 | -86.5% | 0.11% | -88.5% |
| Q1 2019 | $12,989,000 | +22.0% | 185,425 | +12.2% | 0.99% | +19.8% |
| Q4 2018 | $10,648,000 | +78.9% | 165,310 | +95.0% | 0.83% | +93.9% |
| Q3 2018 | $5,953,000 | +9.0% | 84,778 | -21.7% | 0.43% | +8.6% |
| Q2 2018 | $5,459,000 | +171.2% | 108,316 | +68.3% | 0.39% | +160.9% |
| Q1 2018 | $2,013,000 | +41.4% | 64,346 | +44.9% | 0.15% | +55.7% |
| Q3 2017 | $1,424,000 | -27.7% | 44,405 | -26.7% | 0.10% | -32.6% |
| Q2 2017 | $1,970,000 | +29.3% | 60,541 | +25.1% | 0.14% | +35.8% |
| Q1 2017 | $1,523,000 | -49.8% | 48,379 | -53.1% | 0.11% | -49.3% |
| Q4 2016 | $3,034,000 | +48.4% | 103,262 | +46.0% | 0.21% | +42.2% |
| Q3 2016 | $2,044,000 | – | 70,708 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $56,620,000 | 5.32% |
| Baker Brothers Advisors | 13,655,618 | $386,590,000 | 4.87% |
| NORTH TIDE CAPITAL, LLC | 1,500,000 | $42,465,000 | 3.24% |
| Murphy Michael R | 291,292 | $8,246,000 | 2.85% |
| Tributary Capital Management, LLC | 111,244 | $3,149,000 | 0.66% |
| Champlain Investment Partners, LLC | 1,234,780 | $34,957,000 | 0.61% |
| IRONBRIDGE CAPITAL MANAGEMENT LP | 454,085 | $12,855,000 | 0.34% |
| STONEBRIDGE CAPITAL MANAGEMENT INC | 27,180 | $769,000 | 0.30% |
| Motley Fool Asset Management LLC | 36,179 | $1,139,000 | 0.24% |
| Kimelman & Baird, LLC | 35,800 | $1,013,000 | 0.19% |